Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The genetic background of acromegaly
Mônica R. Gadelha, Leandro Kasuki, Márta Korbonits
Pituitary (2017) Vol. 20, Iss. 1, pp. 10-21
Open Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

Acromegaly
Annamaria Colao, Ludovica F. S. Grasso, Andrea Giustina, et al.
Nature Reviews Disease Primers (2019) Vol. 5, Iss. 1
Open Access | Times Cited: 319
A standardised diagnostic approach to pituitary neuroendocrine tumours (PitNETs): a European Pituitary Pathology Group (EPPG) proposal
Chiara Villa, Alexandre Vasiljevic, Marie-Lise Jaffrain-Réa, et al.
Virchows Archiv (2019) Vol. 475, Iss. 6, pp. 687-692
Closed Access | Times Cited: 88
Gαs–Protein Kinase A (PKA) Pathway Signalopathies: The Emerging Genetic Landscape and Therapeutic Potential of Human Diseases Driven by Aberrant Gαs-PKA Signaling
Dana J. Ramms, Francesco Raimondi, Nadia Arang, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 4, pp. 1326-1368
Open Access | Times Cited: 52
Genetics of Acromegaly and Gigantism
Anna Bogusławska, Márta Korbonits
Journal of Clinical Medicine (2021) Vol. 10, Iss. 7, pp. 1377-1377
Open Access | Times Cited: 47
Molecular genetic testing in the management of pituitary disease
Eva C Coopmans, Márta Korbonits
Clinical Endocrinology (2022) Vol. 97, Iss. 4, pp. 424-435
Open Access | Times Cited: 36
Aggressive tumor growth and clinical evolution in a patient with X-linked acro-gigantism syndrome
Luciana Ansaneli Naves, Adrian Daly, Luiz Augusto Dias, et al.
Endocrine (2015) Vol. 51, Iss. 2, pp. 236-244
Open Access | Times Cited: 53
Biochemical Control in Acromegaly With Multimodality Therapies: Outcomes From a Pituitary Center and Changes Over Time
Alireza Ghajar, Pamela S. Jones, Francisco J. Guarda, et al.
The Journal of Clinical Endocrinology & Metabolism (2019) Vol. 105, Iss. 3, pp. e532-e543
Open Access | Times Cited: 40
Predictors for Remission after Transsphenoidal Surgery in Acromegaly: A Dutch Multicenter Study
Eva C Coopmans, Mark R Postma, Thalijn L C Wolters, et al.
The Journal of Clinical Endocrinology & Metabolism (2021) Vol. 106, Iss. 6, pp. 1783-1792
Open Access | Times Cited: 29
Genetic causes of familial pituitary tumors
Anna Bogusławska, Maria Manuel Costa, Márta Korbonits
Elsevier eBooks (2025)
Closed Access
Massive aortic root dilation in a Young male with previously undiagnosed acromegaly: a case report and review
Mahmoud Gomaa, Hassan El-Shirbiny, Osama S. El-Shaer
Oxford Medical Case Reports (2025) Vol. 2025, Iss. 2
Open Access
Copeptin and Mid-Regional Proadrenomedullin Are Not Useful Biomarkers of Cardiometabolic Disease in Patients with Acromegaly—A Preliminary Study
Martyna Strzelec, Eliza Kubicka, Justyna Kuliczkowska-Płaksej, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 666-666
Open Access
Clinical MEN-1 Among a Large Cohort of Patients With Acromegaly
Lisa B. Nachtigall, Francisco J. Guarda, Kate E Lines, et al.
The Journal of Clinical Endocrinology & Metabolism (2020) Vol. 105, Iss. 6, pp. e2271-e2281
Open Access | Times Cited: 29
The Pathogenic RET Val804Met Variant in Acromegaly: A New Clinical Phenotype?
Sabrina Chiloiro, Ettore Capoluongo, Flavia Costanza, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1895-1895
Open Access | Times Cited: 3
Unlocking the Genetic Secrets of Acromegaly: Exploring the Role of Genetics in a Rare Disorder
Ioana Balinisteanu, Lavinia Caba, Andreea Florea, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 8, pp. 9093-9121
Open Access | Times Cited: 3
Molecular determinants of the response to medical treatment of growth hormone secreting pituitary neuroendocrine tumors
Antonio C. Fuentes-Fayos, Araceli García‐Martínez, Aura D. Herrera‐Martínez, et al.
Minerva Endocrinologica (2019) Vol. 44, Iss. 2
Closed Access | Times Cited: 26
The Genetic Architecture of High Bone Mass
Celia L. Gregson, Emma L. Duncan
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 24
The Relationship between TLR3 rs3775291 Polymorphism and Infectious Diseases: A Meta-Analysis of Case-Control Studies
Marcos Jessé Abrahão Silva, Caroliny Soares Silva, Marcelo Cleyton da Silva Vieira, et al.
Genes (2023) Vol. 14, Iss. 7, pp. 1311-1311
Open Access | Times Cited: 8
Familial X-Linked Acrogigantism: Postnatal Outcomes and Tumor Pathology in a Prenatally Diagnosed Infant and His Mother
Brittany K. Wise-Oringer, George Zanazzi, Rebecca J. Gordon, et al.
The Journal of Clinical Endocrinology & Metabolism (2019) Vol. 104, Iss. 10, pp. 4667-4675
Open Access | Times Cited: 25
Acromegaly caused by a somatotroph adenoma in patient with neurofibromatosis type 1
Kaori Hozumi, Hidenori Fukuoka, Yukiko Odake, et al.
Endocrine Journal (2019) Vol. 66, Iss. 10, pp. 853-857
Open Access | Times Cited: 23
Endocrine causes of hypertension: literature review and practical approach
Jean-Baptiste de Fréminville, Laurence Amar, Michel Azizi, et al.
Hypertension Research (2023) Vol. 46, Iss. 12, pp. 2679-2692
Closed Access | Times Cited: 7
Guidelines on diagnostics and treatment of acromegaly (draft)
Elena Przhiyalkovskaya, Н. Г. Мокрышева, Е. А. Трошина, et al.
Obesity and metabolism (2024) Vol. 21, Iss. 2, pp. 215-249
Open Access | Times Cited: 2
Oral Manifestations and Maxillo-Facial Features in the Acromegalic Patient: A Literature Review
Alberto De Stefani, Francesca Dassie, Alexandra Wennberg, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 4, pp. 1092-1092
Open Access | Times Cited: 12
“Micromegaly”: Acromegaly with apparently normal GH, an entity on its own?
Lúcio Vilar, Luciana Ansaneli Naves, Manoel Ricardo Alves Martins, et al.
Best Practice & Research Clinical Endocrinology & Metabolism (2024) Vol. 38, Iss. 3, pp. 101878-101878
Closed Access | Times Cited: 2
Diagnosis, treatment and follow-up of patients with acromegaly in a clinical practice setting in Spain: the ACROPRAXIS program Delphi survey
Pedro de Pablos‐Velasco, Eva Venegas, Cristina Álvarez‐Escolá, et al.
Pituitary (2019) Vol. 23, Iss. 2, pp. 129-139
Open Access | Times Cited: 16
gsp Mutation Is Not a Molecular Biomarker of Long-Term Response to First-Generation Somatostatin Receptor Ligands in Acromegaly
Luiz Eduardo Wildemberg, Daniel G. Henriques, Paula Condé Lamparelli Elias, et al.
Cancers (2021) Vol. 13, Iss. 19, pp. 4857-4857
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top